Diabetes Research and Clinical Practice
Volume 75, Issue 1 , Pages 81-87 , January 2007

A simple nurse-based prompt increases screening and prevention counseling for diabetes

  • John M. Boltri

      Affiliations

    • Department of Family Medicine, Mercer University School of Medicine, Macon, GA, United States
    • Corresponding Author InformationCorresponding author at: Department of Family Medicine, Mercer University School of Medicine, 3780 Eisenhower Parkway, Macon, GA 31206, United States. Tel.: +1 478 633 5550; fax: +1 478 784 5496.
    • ,
  • Ike Okosun

      Affiliations

    • Institute of Public Health, Georgia State University, Atlanta, United States
    • ,
  • Y. Monique Davis-Smith

      Affiliations

    • Department of Family Medicine, Mercer University School of Medicine, Macon, GA, United States
    • ,
  • J. Paul Seale

      Affiliations

    • Department of Family Medicine, Mercer University School of Medicine, Macon, GA, United States
    • ,
  • Phil Roman

      Affiliations

    • Department of Family Medicine, Mercer University School of Medicine, Macon, GA, United States
    • ,
  • Brian W. Tobin

      Affiliations

    • Department of Basic Sciences, Mercer University School of Medicine, Macon, GA, United States

Received 25 April 2006 ,Accepted 4 May 2006.

References 

  1. Centers for Disease Control, Prevention. Prevalence of diabetes and impaired fasting glucose in adults, United States, 1999–2000. MMWR. 2003;52:833–837
  2. Benjamin SM, Valdez R, Geiss LS, Rolka DB, Narayan KM. Estimated number of adults with prediabetes in the US in 2000: opportunities for prevention. Diab Care. 2003;26:645–649
  3. Diabetes Control, Complications Trial Research Group. Lifetime benefits and costs of intensive therapy as practiced in the diabetes control and complications trial. JAMA. 1996;276:1409–1415
  4. The absence of a glycemic threshold for the development of long-term complications: the perspective of the diabetes control, complications, trial. Diabetes. 1996;45:1289–1298
  5. The relationship of glycemic exposure (HbA1c) to the risk of development, progression of retinopathy in the diabetes control, complications trial. Diabetes. 1995;44:968–983
  6. UK., Prospective Diabetes Study Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998;352:837–853
  7. UK, Prospective Diabetes Study Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet. 1998;352:854–865
  8. UK, Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ. 1998;317:703–713
  9. UK, Prospective Diabetes Study Group. Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39. BMJ. 1998;317:713–720
  10. Diabetes Control, Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329:977–986
  11. Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, et al. Diabetes prevention program research group: reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346:393–403
  12. Tuomilehto J, Lindstrom J, Eriksson JG, Valle TT, Hamalainen H, Ilanne-Parikka P, et al. Finnish diabetes prevention study group: prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med. 2001;344:1343–1350
  13. Pan XR, Li GW, Hu YH, Wang JX, Yang WY, An ZX, et al. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The da qing IGT and diabetes study. Diab Care. 1997;20:537–544
  14. American Diabetes Association. Standards of medical care in diabetes-. Diab Care. 2006;29(Suppl 1):S4–S42
  15. American College of Endocrinology. Consensus statement on guidelines for glycemic control [article online]. Endocr Pract. 2002;8:5–11Available from http://www.aace.com/meetings/consensus/dcc/pdf/dccwhitepaper.pdf
  16. Boltri JM, Okosun IS, Davis-Smith M, Vogel RL. Hemoglobin A1c levels in diagnosed and undiagnosed Black, Hispanic and white persons with diabetes: results from NHANES 1999-2000. Ethn Dis. 2005;15:562–567
  17. Zhang P, Engelgau MM, Valdez R, Benjamin SM, Cadwell B, Narayan KM. Costs of screening for pre-diabetes among US adults: a comparison of different screening strategies. Diab Care. 2003;26:2536–2542
  18. Johnson SL, Tabaei BP, Herman WH. The efficacy and cost of alternative strategies for systematic screening for type 2 diabetes in the US population 45–74 years of age. Diab Care. 2005;28:307–311
  19. Zhang P, Engelgau MM, Valdez R, Cadwell B, Benjamin SM, Narayan KM. Efficient cutoff points for three screening tests for detecting undiagnosed diabetes and pre-diabetes: an economic analysis. Diab Care. 2005;28:1321–1325
  20. Colagiuri S, Hussain Z, Zimmet P, Cameron A, Shaw J. AusDiab: screening for type 2 diabetes and impaired glucose metabolism: the Australian experience. Diab Care. 2004;27:367–371
  21. Icks A, Haastert B, Gandjour A, John J, Lowel H, Holle R, et al. KORA study group: cost-effectiveness analysis of different screening procedures for type 2 diabetes: the KORA survey. Diab Care. 2004;27:2120–2128
  22. Harwell TS, Smilie JG, McDowall JM, Helgerson SD, Gohdes D. Diabetes screening practices among individuals aged 45 years and older. Diab Care. 2000;23:125–126
  23. Ealovega MW, Tabaei BP, Brandle M, Burke R, Herman WH. Opportunistic screening for diabetes in routine clinical practice. Diab Care. 2004;27:9–12
  24. Edelman D, Edwards LJ, Olsen MK, Dudley TK, Harris AC, Blackwell DK, et al. Screening for diabetes in an outpatient clinic population. J Gen Intern Med. 2002;17:23–28
  25. Christensen JO, Sandbaek A, Lauritzen T, Borch-Johnsen K. Population-based stepwise screening for unrecognised type 2 diabetes is ineffective in general practice despite reliable algorithms. Diabetologia. 2004;47:1566–1573
  26. Tabaei BP, Burke R, Constance A, Hare J, May-Aldrich G, Parker SA, et al. Community-based screening for diabetes in Michigan. Diab Care. 2003;26:668–670
  27. Schmittdiel J, McMenamin SB, Halpin HA, Gillies RR, Bodenheimer T, Shortell SM, et al. The use of patient and physician reminders for preventive services: results from a national study of physician organizations. Prev Med. 2004;39:1000–1006
  28. McIsaac WJ, Goel V, To T, Permaul JA, Low DE. Effect on antibiotic prescribing of repeated clinical prompts to use a sore throat score: lessons from a failed community intervention study. J Fam Pract. 2002;51:339–344
  29. Bordley WC, Margolis PA, Stuart J, Lannon C, Keyes L. Improving preventive service delivery through office systems. Pediatrics. 2001;108:E41
  30. American Diabetes Association. Screening for type 2 diabetes. Diab Care. 2003;26(Suppl 1):S21–S24
  31. Kohner EM, Aldington SJ, Stratton IM, Manley SE, Holman RR, Matthews DR, et al. United Kingdom prospective diabetes study, 30 diabetic retinopathy at diagnosis of non-insulin-dependent diabetes mellitus and associated risk factors. Arch Ophthalmol. 1998;116:297–303
  32. Rajala U, Laakso M, Qiao Q, Keinanen-Kiukaanniemi S. Prevalence of retinopathy in people with diabetes, impaired glucose tolerance, and normal glucose tolerance. Diab Care. 1998;21:1664–1669
  33. Ballard DJ, Humphrey LL, Melton LJ, Frohnert PP, Chu PC, O’Fallon WM, et al. Epidemiology of persistent proteinuria in type II diabetes mellitus. population-based study in Rochester, Minnesota. Diabetes. 1988;37:405–412
  34. Drivsholm T, de Fine Olivarius N, Nielsen AB, Siersma V. Symptoms, signs and complications in newly diagnosed type 2 diabetic patients, and their relationship to glycaemia, blood pressure and weight. Diabetologia. 2005;48:210–214
  35. Hillier TA, Pedula KL. Characteristics of an adult population with newly diagnosed type 2 diabetes: the relation of obesity and age of onset. Diab Care. 2001;24:1522–1527
  36. Yarnall KS, Pollak KI, Ostbye T, Krause KM, Michener JL. Primary care: is there enough time for prevention?. Am J Public Health. 2003;93:635–641

☆ This project was supported in part by grants from the Medcen Foundation, Macon Georgia, the US Department of Health and Human Services, Health Resources and Services Administration (HRSA), Grant #5D12HP00159, and National Institutes of Health Grant #1 K07 HL04305-01.

PII: S0168-8227(06)00176-8

doi: 10.1016/j.diabres.2006.05.002

Diabetes Research and Clinical Practice
Volume 75, Issue 1 , Pages 81-87 , January 2007

Article Tools